John Meacock

John Meacock is an accomplished executive with extensive experience in strategy and governance across various sectors. Currently serving as an Advisory Board Member at ABN Group and Chair at both Centerstone Capital and 6clicks, Meacock leverages expertise in private equity and governance, risk, and compliance. A Non-Executive Director at the Garvan Institute Medical Research Foundation and Clear Dynamics Pty Ltd, Meacock contributes to advancements in genomic medicine and AI technology. Meacock's previous role as Global Chief Strategy Officer at Deloitte involved driving significant strategic initiatives and fostering global integration. A founding member of Oakvale Capital Limited, Meacock established it as Australia's leading independent treasury and financial advisory firm. Educational credentials include degrees from The University of Western Australia and fellowships from the Australian Institute of Company Directors and the Institute of Chartered Accountants in Australia, among other prestigious institutions.